RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Prevail Partners
P

Prevail Partners portfolio

Prevail Partners has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Rounds led: 1 of 2.
Capital in their rounds: $28M.
Latest deal: Omnix Medical · Oct 15, 2025.
About this page

It led 1 of the 2 rounds it joined. Its most recent investment on record is Omnix Medical's $25M Series B+ round in October 2025, alongside OurCrowd, Oriella Ltd., Harel Insurance and Financial and 4 others. By category, its portfolio leans toward Health and bio (2) and AI agents (1). It has co-invested with Entrée Capital, European Innovation Council Fund and Harel Insurance and Financial.

What Prevail Partners invests in

How Prevail Partners invests

StageDealsCapital in rounds
Seed 1 50%$3M
Series B+ 1 50%$25M

Prevail Partners portfolio companies

CompanyRound with Prevail PartnersTotal raisedLatest raise
OOmnix Medical
AI agents
Series B+ · $25M$25MOct 15, 2025
Series B+
CCoologics
Health and bio
Seed · $3M · lead$3MApr 23, 2025
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Prevail Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Prevail Partners, which is a subset of its real portfolio. API: /api/v1/investors/prevail-partners (get a free API key). More: the most active VC firms and new venture capital funds.